These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. Johnson WC; Lee KK J Vasc Surg; 2000 Aug; 32(2):268-77. PubMed ID: 10917986 [TBL] [Abstract][Full Text] [Related]
4. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: Polytetrafluoroethylene graft versus reversed saphenous vein. Ballotta E; Renon L; Toffano M; Da Giau G J Vasc Surg; 2003 Nov; 38(5):1051-5. PubMed ID: 14603216 [TBL] [Abstract][Full Text] [Related]
5. Graft type for femoro-popliteal bypass surgery. Mamode N; Scott RN Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649 [TBL] [Abstract][Full Text] [Related]
6. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? QuiƱones-Baldrich WJ; Busuttil RW; Baker JD; Vescera CL; Ahn SS; Machleder HI; Moore WS J Vasc Surg; 1988 Sep; 8(3):219-28. PubMed ID: 3418827 [TBL] [Abstract][Full Text] [Related]
7. Femoropopliteal bypass for claudication: vein vs. PTFE. Allen BT; Reilly JM; Rubin BG; Thompson RW; Anderson CB; Flye MW; Sicard GA Ann Vasc Surg; 1996 Mar; 10(2):178-85. PubMed ID: 8733871 [TBL] [Abstract][Full Text] [Related]
8. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Archie JP Ann Vasc Surg; 1994 Sep; 8(5):475-84. PubMed ID: 7811585 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts. Sala F; Hassen-Khodja R; Lecis A; Bouillanne PJ; Declemy S; Batt M Ann Vasc Surg; 2003 Jul; 17(4):401-7. PubMed ID: 14670018 [TBL] [Abstract][Full Text] [Related]
10. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts. Jackson MR; Belott TP; Dickason T; Kaiser WJ; Modrall JG; Valentine RJ; Clagett GP J Vasc Surg; 2000 Sep; 32(3):498-504; 504-5. PubMed ID: 10957656 [TBL] [Abstract][Full Text] [Related]
11. Above-knee femoropopliteal reconstruction with polytetrafluoroethylene: a good alternative to saphenous vein bypass. Laurendeau F; Lassonde J Can J Surg; 1989 Jan; 32(1):48-50. PubMed ID: 2910380 [TBL] [Abstract][Full Text] [Related]
12. Femoropopliteal bypass: saphenous vein and expanded polytetrafluoroethylene grafts. Wooster DL; Provan JL; Sojka SG; Madras PN Can J Surg; 1982 Nov; 25(6):666-9. PubMed ID: 7139424 [TBL] [Abstract][Full Text] [Related]
13. Peripheral reconstruction when adequate saphenous vein is lacking. Myhre HO Acta Chir Scand Suppl; 1985; 529():73-5. PubMed ID: 2938388 [TBL] [Abstract][Full Text] [Related]
14. Graft type for femoro-popliteal bypass surgery. Twine CP; McLain AD Cochrane Database Syst Rev; 2010 May; (5):CD001487. PubMed ID: 20464717 [TBL] [Abstract][Full Text] [Related]
15. The current status of femoropopliteal bypass grafting. Mulherin JL; Edwards WH Am Surg; 1980 May; 46(5):273-8. PubMed ID: 6992668 [TBL] [Abstract][Full Text] [Related]
17. Late results of two hundred seventeen femoropopliteal bypasses to isolated popliteal artery segments. Kram HB; Gupta SK; Veith FJ; Wengerter KR; Panetta TF; Nwosisi C J Vasc Surg; 1991 Sep; 14(3):386-90. PubMed ID: 1880847 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Long-Term Outcomes of Femoropopliteal Bypass Surgery in Patients With Chronic Limb-Threatening Ischemia in an Endovascular Era. Betz T; Ingolf T; Markus S; Florian Z; Christian U Ann Vasc Surg; 2022 Feb; 79():191-200. PubMed ID: 34644653 [TBL] [Abstract][Full Text] [Related]